Lv1
40 积分 2021-10-11 加入
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis
24分钟前
待确认
Surgical Management of Gynecologic Cancers
3年前
已完结
皖公网安备34019202002308
